Tag Archives: McKesson Life Sciences

Specialty Pharmacy

BluePrint’s AYVAKIT and GAVRETO™ Selected Biologics and PantherRx Rare as Limited Specialty Pharmacies

Posted on by John Santilli
15
Jan

Blueprint creates medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease

Continue reading →
Specialty Drug, Specialty Pharmacy

Immunomedics Chooses Biologics as Sole Specialty Pharmacy Distributor

Posted on by John Santilli
18
May

Trodelvy is the first anti-Trop-2 ADC recently approved by the FDA for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease

Continue reading →